KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Goodwill (2016 - 2025)

Charles River Laboratories International has reported Goodwill over the past 17 years, most recently at $2.8 billion for Q4 2025.

  • For Q4 2025, Goodwill fell 2.89% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $2.8 billion, down 2.89%, while the annual FY2025 figure was $2.8 billion, 2.89% down from the prior year.
  • Goodwill for Q4 2025 was $2.8 billion at Charles River Laboratories International, down from $2.9 billion in the prior quarter.
  • Over five years, Goodwill peaked at $3.1 billion in Q3 2024 and troughed at $1.9 billion in Q1 2021.
  • A 5-year average of $2.8 billion and a median of $2.9 billion in 2022 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: surged 49.9% in 2021 and later fell 8.03% in 2024.
  • Year by year, Goodwill stood at $2.7 billion in 2021, then grew by 5.09% to $2.8 billion in 2022, then increased by 8.6% to $3.1 billion in 2023, then fell by 8.03% to $2.8 billion in 2024, then dropped by 2.89% to $2.8 billion in 2025.
  • Business Quant data shows Goodwill for CRL at $2.8 billion in Q4 2025, $2.9 billion in Q3 2025, and $2.9 billion in Q2 2025.